Skip to main content

FDA Updates

FDA Approves Rucaparib and Companion Diagnostic for Patients with Advanced Ovarian Cancer

Venclexta (Venetoclax) First BCL-2 Inhibitor Approved for High-Risk Relapsed Chronic Lymphocytic Leukemia

Daratumumab Combination Approved for Multiple Myeloma

Sustol, First Extended-Release 5-HT3 Approved for the Prevention of CINV

Cabometyx Receives FDA Approval for Advanced Renal-Cell Carcinoma

Olaratumab Approved for Use with Doxorubicin in Adults with Advanced Soft-Tissue Sarcoma

Atezolizumab First PD-L1 Inhibitor Approved for the Treatment of Patients with Metastatic NSCLC

Pembrolizumab Approved for Patients with Head and Neck Cancer

Monthly Injection Approved for Patients with Relapsed Multiple Sclerosis

Netspot Approved for Detection of Neuroendocrine Tumors

24
25
26
27
28
29
30

Page 27 of 33
Results 261 - 270 of 330